Terumo Corporation is a Japan-based global medical technology company that develops, manufactures, and supplies devices and systems for vascular intervention, cardiothoracic surgery, transfusion and infusion therapy, and blood and cell management. Serving hospitals, blood centers, and life-science laboratories worldwide, its portfolio includes catheters, stents, guidewires, syringes and needles, infusion devices, perfusion and oxygenation systems, vascular grafts, and platforms for blood component and cell processing.
The company operates through businesses such as Terumo Interventional Systems, Terumo Aortic, Terumo Blood and Cell Technologies (Terumo BCT), and Terumo Medical Corporation in the Americas. Headquartered in Tokyo with manufacturing and R&D across Asia, Europe, and the Americas, Terumo is listed on the Tokyo Stock Exchange. Its technologies support clinical areas including cardiology, endovascular therapy, oncology, critical care, and transfusion medicine.
To provide comprehensive coverage, we aggregate data and news under the name Terumo, encompassing the following company names, divisions, and related entities:
Terumo Blood and Cell Technologies, Terumo BCT, Terumo Medical Corporation, Terumo Interventional Systems, Terumo Corporation, and Terumo Aortic.
This list encompasses current and former names, alternate names, and key divisions associated with Terumo, ensuring you can easily find all relevant information under a single, unified profile.
